These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 31559249)

  • 61. Skin Barrier and Autoimmunity-Mechanisms and Novel Therapeutic Approaches for Autoimmune Blistering Diseases of the Skin.
    Stevens NE; Cowin AJ; Kopecki Z
    Front Immunol; 2019; 10():1089. PubMed ID: 31156638
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Epidermolysis bullosa acquisita: A comprehensive review.
    Kridin K; Kneiber D; Kowalski EH; Valdebran M; Amber KT
    Autoimmun Rev; 2019 Aug; 18(8):786-795. PubMed ID: 31181325
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Autoimmune blistering skin diseases.
    Cotell S; Robinson ND; Chan LS
    Am J Emerg Med; 2000 May; 18(3):288-99. PubMed ID: 10830686
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Autoimmune blistering skin diseases in childhood.
    Marinović B; Jukić IL
    Acta Dermatovenerol Croat; 2002 Mar; 10(1):33-7. PubMed ID: 12137729
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Case of epidermolysis bullosa acquisita with concomitant anti-laminin-332 antibodies.
    Nishida E; Nishio E; Murashima H; Ishii N; Hashimoto T; Morita A
    J Dermatol; 2018 Apr; 45(4):472-474. PubMed ID: 29205468
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Autoimmune bullous diseases.
    Rye B; Webb JM
    Am Fam Physician; 1997 Jun; 55(8):2709-18. PubMed ID: 9191456
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Current treatment of autoimmune blistering diseases.
    Kasperkiewicz M; Schmidt E
    Curr Drug Discov Technol; 2009 Dec; 6(4):270-80. PubMed ID: 20025595
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Consensus on the treatment of autoimmune bullous dermatoses: bullous pemphigoid, mucous membrane pemphigoid and epidermolysis bullosa acquisita - Brazilian Society of Dermatology.
    Santi CG; Gripp AC; Roselino AM; Mello DS; Gordilho JO; Marsillac PF; Porro AM
    An Bras Dermatol; 2019 Apr; 94(2 Suppl 1):33-47. PubMed ID: 31166405
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Retrospective Study on Autoimmune Blistering Disease in Paediatric Patients.
    Kong YL; Lim YL; Chandran NS
    Pediatr Dermatol; 2015; 32(6):845-52. PubMed ID: 26391853
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Autoimmune blistering diseases in the elderly.
    Parker SR; MacKelfresh J
    Clin Dermatol; 2011; 29(1):69-79. PubMed ID: 21146735
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Autoimmune subepidermal blistering diseases in Uganda: correlation of autoantibody class with age of patients.
    Mulyowa GK; Jaeger G; Kabakyenga J; Bröcker EB; Zillikens D; Schmidt E
    Int J Dermatol; 2006 Sep; 45(9):1047-52. PubMed ID: 16961507
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany.
    Bertram F; Bröcker EB; Zillikens D; Schmidt E
    J Dtsch Dermatol Ges; 2009 May; 7(5):434-40. PubMed ID: 19170813
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Paraneoplastic Pemphigus and Autoimmune Blistering Diseases Associated with Neoplasm: Characteristics, Diagnosis, Associated Neoplasms, Proposed Pathogenesis, Treatment.
    Kartan S; Shi VY; Clark AK; Chan LS
    Am J Clin Dermatol; 2017 Feb; 18(1):105-126. PubMed ID: 27878477
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Recent progress in studies on autoantigens for various autoimmune blistering skin diseases.
    Hashimoto T
    Keio J Med; 1995 Dec; 44(4):115-23. PubMed ID: 8587223
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A Review Comparing International Guidelines for the Management of Bullous Pemphigoid, Pemphigoid Gestationis, Mucous Membrane Pemphigoid, and Epidermolysis Bullosa Acquisita.
    Patel PM; Jones VA; Murray TN; Amber KT
    Am J Clin Dermatol; 2020 Aug; 21(4):557-565. PubMed ID: 32180161
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A review of high-dose intravenous immunoglobulin (hdIVIg) in the treatment of the autoimmune blistering disorders.
    Jolles S
    Clin Exp Dermatol; 2001 Mar; 26(2):127-31. PubMed ID: 11298100
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Bullous pemphigoid.
    Korman N
    J Am Acad Dermatol; 1987 May; 16(5 Pt 1):907-24. PubMed ID: 3294944
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Autoimmune blistering diseases].
    Duvert-Lehembre S; Joly P
    Rev Med Interne; 2014 Mar; 35(3):166-73. PubMed ID: 23747156
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Unusual subepidermal bullous diseases with immunologic features of bullous pemphigoid.
    Provost TT; Maize JC; Ahmed AR; Strauss JS; Dobson RL
    Arch Dermatol; 1979 Feb; 115(2):156-60. PubMed ID: 371547
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The Significance of Scalp Involvement in Pemphigus: A Literature Review.
    Sar-Pomian M; Rudnicka L; Olszewska M
    Biomed Res Int; 2018; 2018():6154397. PubMed ID: 29770335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.